These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20443815)

  • 1. Immunostimulatory effects of mesenchymal stem cell-derived neurons: implications for stem cell therapy in allogeneic transplantations.
    Castillo MD; Trzaska KA; Greco SJ; Ponzio NM; Rameshwar P
    Clin Transl Sci; 2008 May; 1(1):27-34. PubMed ID: 20443815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing effect of IL-1alpha on neurogenesis from adult human mesenchymal stem cells: implication for inflammatory mediators in regenerative medicine.
    Greco SJ; Rameshwar P
    J Immunol; 2007 Sep; 179(5):3342-50. PubMed ID: 17709551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart.
    Huang XP; Ludke A; Dhingra S; Guo J; Sun Z; Zhang L; Weisel RD; Li RK
    FASEB J; 2016 Sep; 30(9):3069-82. PubMed ID: 27221978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells.
    Greco SJ; Rameshwar P
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15484-9. PubMed ID: 17855557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-induced increase in Sug1 leads to poor post-transplantation survival of allogeneic mesenchymal stem cells.
    Abu-El-Rub E; Sareen N; Lester Sequiera G; Ammar HI; Yan W; ShamsEldeen AM; Rubinchik I; Moudgil M; Shokry HS; Rashed LA; Dhingra S
    FASEB J; 2020 Sep; 34(9):12860-12876. PubMed ID: 32770803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA.
    Tang KC; Trzaska KA; Smirnov SV; Kotenko SV; Schwander SK; Ellner JJ; Rameshwar P
    J Immunol; 2008 Feb; 180(3):1826-33. PubMed ID: 18209080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of equine induced pluripotent stem cells into mesenchymal lineage for therapeutic use.
    Chung MJ; Park S; Son JY; Lee JY; Yun HH; Lee EJ; Lee EM; Cho GJ; Lee S; Park HS; Jeong KS
    Cell Cycle; 2019 Nov; 18(21):2954-2971. PubMed ID: 31505996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo.
    Isakova IA; Lanclos C; Bruhn J; Kuroda MJ; Baker KC; Krishnappa V; Phinney DG
    PLoS One; 2014; 9(1):e87238. PubMed ID: 24489878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma.
    Chan JL; Tang KC; Patel AP; Bonilla LM; Pierobon N; Ponzio NM; Rameshwar P
    Blood; 2006 Jun; 107(12):4817-24. PubMed ID: 16493000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison of the immunogenicity of major histocompatibility complex-I and -II deficient mesenchymal stem cells
    Halm D; Leibig N; Martens J; Stark GB; Groß T; Zimmermann S; Finkenzeller G; Lampert F
    Biol Chem; 2021 May; 402(6):693-702. PubMed ID: 33544464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a modulates genes involved in cellular motility and oxidative phosphorylation in neural precursors derived from human umbilical cord mesenchymal stem cells.
    Chang SJ; Weng SL; Hsieh JY; Wang TY; Chang MD; Wang HW
    BMC Med Genomics; 2011 Sep; 4():65. PubMed ID: 21923954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
    Poncelet AJ; Vercruysse J; Saliez A; Gianello P
    Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.
    Fu X; Chen Y; Xie FN; Dong P; Liu WB; Cao Y; Zhang WJ; Xiao R
    Tissue Eng Part A; 2015 Feb; 21(3-4):616-26. PubMed ID: 25256849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunobiological development of human bone marrow mesenchymal stem cells in the course of neuronal differentiation.
    Liu CT; Yang YJ; Yin F; Wang X; Yu XH; Wang QH; Wang XL; Xie M
    Cell Immunol; 2006 Nov; 244(1):19-32. PubMed ID: 17448455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.
    Schnabel LV; Pezzanite LM; Antczak DF; Felippe MJ; Fortier LA
    Stem Cell Res Ther; 2014 Jan; 5(1):13. PubMed ID: 24461709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC Class I Enables MSCs to Evade NK-Cell-Mediated Cytotoxicity and Exert Immunosuppressive Activity.
    Oh JY; Kim H; Lee HJ; Lee K; Barreda H; Kim HJ; Shin E; Bae EH; Kaur G; Zhang Y; Kim E; Lee JY; Lee RH
    Stem Cells; 2022 Sep; 40(9):870-882. PubMed ID: 35852488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunomodulation-immunogenicity balance of equine Mesenchymal Stem Cells (MSCs) is differentially affected by the immune cell response depending on inflammatory licensing and major histocompatibility complex (MHC) compatibility.
    Cequier A; Vázquez FJ; Romero A; Vitoria A; Bernad E; García-Martínez M; Gascón I; Barrachina L; Rodellar C
    Front Vet Sci; 2022; 9():957153. PubMed ID: 36337202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies.
    Berglund AK; Schnabel LV
    Equine Vet J; 2017 Jul; 49(4):539-544. PubMed ID: 27862236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase 3β inhibitor- CHIR 99021 augments the differentiation potential of mesenchymal stem cells.
    Govarthanan K; Vidyasekar P; Gupta PK; Lenka N; Verma RS
    Cytotherapy; 2020 Feb; 22(2):91-105. PubMed ID: 31980369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
    Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
    Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.